Our KEGG enrichment analysis results implied that another possible function of FGF9 in liver cancer is the activation of inflammation, a feature also associated with NASH.[51] This possibility is further supported by the expression of inflammatory factors, such as TNF‐α, IL‐6 and IL‐1β, in the livers of FGF9 TG mice. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.